BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
4.800
+0.280 (6.19%)
Apr 21, 2026, 11:56 AM EST
BioStem Technologies Market Cap
BioStem Technologies has a market cap or net worth of $76.65 million as of April 21, 2026. Its market cap has decreased by -45.69% in one year.
Market Cap
76.65M
Enterprise Value
50.44M
Revenue
47.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.80
Market Cap Chart
Since August 4, 2009, BioStem Technologies's market cap has increased from 4.77M to 76.65M, an increase of 1,505.54%. That is a compound annual growth rate of 18.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 76.65M | 19.75% |
| Dec 31, 2025 | 64.01M | -72.22% |
| Dec 31, 2024 | 230.43M | 143.12% |
| Dec 29, 2023 | 94.78M | 160.66% |
| Dec 30, 2022 | 36.36M | 267.00% |
| Dec 30, 2021 | 9.91M | -25.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 355.67M |
| Northwest Biotherapeutics | 318.36M |
| Vaxart | 180.87M |
| HST Global | 88.40M |
| Nuo Therapeutics | 72.44M |
| Cell Source | 63.19M |
| Vicapsys Life Sciences | 47.26M |
| Harvard Apparatus Regenerative Technology | 27.64M |